03/31/2026
Retatrutide is one of the most common questions I’m getting right now, so let’s clear up the confusion.
You may be hearing about it online as “the next big weight loss drug.” The early data is impressive—but here’s the part that’s getting lost:
Retatrutide is NOT FDA approved and is NOT available to prescribe.
It’s currently still in clinical trials.
So what about the versions being sold online?
Those are being marketed as “research peptides.” That means:
• No regulation
• No guarantee of what’s actually in the vial
• No dosing standards
• No safety oversight
From a medical standpoint, you have no way of knowing:
• if it’s actually retatrutide
• if it’s contaminated
• if the dose is accurate
That’s very different from FDA-approved medications or even properly compounded prescriptions.
Now, to be clear—this is a very promising drug. It works on multiple pathways (including one that may increase energy expenditure), and the early weight loss results are significant.
But promising does not equal proven.
We still need:
• full safety data
• long-term outcomes
• proper regulatory review
Bottom line:
If and when retatrutide is approved, we can absolutely consider it as part of a structured, medically supervised plan.
Until then, the safest and most effective options are the treatments that have already gone through that process.
As always, my goal is not just to get results—but to do it in a way that’s safe, evidence-based, and sustainable.
